Posters
Informational Posters - 1
October 22, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Note: Continuing education credits are not being offered for this session.
Posters
Navigating the National Institute of Diabetes and Digestive and Kidney Diseases
Training and Career Development Programs from the National Institute of Diabetes and Digestive and Kidney Diseases
Research Resources and Funding Opportunities for Clinical, Epidemiologic, Basic, and Translational Kidney Research from the National Institute of Diabetes and Digestive and Kidney Diseases
US Food and Drug Administration (FDA)-Qualified Kidney Safety Biomarker Context of Use: An Anchor for Future Biomarker Qualification
Standard-of-Care and Novel Urine Biomarker Data: The PSTC/FNIH Biomarker Data Repository as a Foundation for Future European Medicines Agency Kidney Biomarker Qualification
The UAB-UCSD O'Brien Center for AKI Research
The University of Michigan George O'Brien Kidney National Research Core: Transforming Translational Kidney Research Through Systems Biology
The NU-USC O'Brien National Resource Center: Integrating Nanotechnology and Physical Sciences for Kidney Health
The Johns Hopkins O'Brien Center: Harnessing Basic, Clinical, and Translational Research to Advance Kidney Health
The Washington University Kidney O'Brien National Resource Center for CKD Research
The Pittsburgh Center for Kidney Research: A Member of the George O'Brien Kidney Resource Alliance
The Indiana University O'Brien National Resource Center
The Clinical Phenotyping Resource and Biobank Core (C-PROBE)
A Phase 3 Study of AND017, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor, in Patients with Anemia Due to Nondialysis-Dependent CKD (NDD-CKD) in the United States
CAPTIVATE: A Global Adaptive Platform Trial for Adults with CKD
Rationale and Design of a Real-World Efficacy and Safety Study of Tenapanor Plus Phosphate Binders (PBs) in Chinese Patients on Hemodialysis with Hyperphosphatemia
Medication Burden Reduction with Tenapanor in Patients on Maintenance Hemodialysis with Hyperphosphatemia Receiving Different Baseline Phosphate Binders: A Multicenter Prospective Cohort Study
Real-World Effectiveness and Safety of Tenapanor in Patients on Peritoneal Dialysis with Hyperphosphatemia: Rationale and Design of a Prospective Multicenter, Single-Arm, Observational Study
Selective Cytopheretic Device Therapy in Cardiorenal Syndrome: Rationale and Study Design of the NEUTRALIZE-CRS Left Ventricular Assist Device (LVAD) Study
PRESERVE-C3Tx, a Phase 3b Pilot Study Design: Effect of Preemptive Pegcetacoplan Use on Recurrence of C3 Glomerulopathy or Primary Immune Complex-Membranoembranoproliferative Glomerulonephritis in Kidney Transplant Recipients
TRANSTELLAR: An Open-Label, Long-Term Extension Study of Felzartamab in Kidney Transplant Recipients with Antibody-Mediated Rejection or Microvascular Inflammation